Haifeng Xu

991 total citations · 1 hit paper
44 papers, 678 citations indexed

About

Haifeng Xu is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Haifeng Xu has authored 44 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 15 papers in Epidemiology and 12 papers in Hepatology. Recurrent topics in Haifeng Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Haifeng Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Haifeng Xu collaborates with scholars based in China, United States and Canada. Haifeng Xu's co-authors include Yanchun Li, Ying Wang, Jing Du, Chen Yang, Yi Zhou, Xueying Ren, Wanye Hu, Chaoting Zhou, Qiangan Jing and Xiangmin Tong and has published in prestigious journals such as Scientific Reports, Radiology and International Journal of Molecular Sciences.

In The Last Decade

Haifeng Xu

38 papers receiving 669 citations

Hit Papers

Overcoming the compensatory elevation of NRF2 renders hep... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haifeng Xu China 14 220 193 165 154 136 44 678
Clément Nguyen France 12 198 0.9× 182 0.9× 648 3.9× 175 1.1× 93 0.7× 19 1.4k
Nuri Karadurmuş Türkiye 16 171 0.8× 98 0.5× 112 0.7× 41 0.3× 236 1.7× 112 712
Xiaolong Yu China 16 105 0.5× 275 1.4× 287 1.7× 62 0.4× 118 0.9× 43 879
Hiromitsu Takizawa Japan 19 537 2.4× 255 1.3× 313 1.9× 98 0.6× 197 1.4× 139 1.3k
Chao Song China 19 404 1.8× 262 1.4× 246 1.5× 67 0.4× 93 0.7× 55 978
Yasunori Shikada Japan 14 323 1.5× 195 1.0× 265 1.6× 104 0.7× 269 2.0× 48 796
Çağatay Arslan Türkiye 19 273 1.2× 91 0.5× 209 1.3× 165 1.1× 437 3.2× 96 924
Finn Ole Larsen Denmark 17 237 1.1× 248 1.3× 88 0.5× 106 0.7× 550 4.0× 49 877
Veerle P. Persy Belgium 17 254 1.2× 245 1.3× 290 1.8× 34 0.2× 84 0.6× 24 1.4k

Countries citing papers authored by Haifeng Xu

Since Specialization
Citations

This map shows the geographic impact of Haifeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Xu more than expected).

Fields of papers citing papers by Haifeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haifeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Xu. The network helps show where Haifeng Xu may publish in the future.

Co-authorship network of co-authors of Haifeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Xu. A scholar is included among the top collaborators of Haifeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Xu. Haifeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Haitao, Meng Yuan, Jiao Wang, et al.. (2024). Genome-wide association analysis of cystatin c and creatinine kidney function in Chinese women. BMC Medical Genomics. 17(1). 272–272. 1 indexed citations
2.
Yao, Fan, Yu Liu, Haifeng Xu, et al.. (2024). Blood-based HYAL2 methylation as a potential marker for the preclinical detection of coronary heart disease and stroke. Clinical Epigenetics. 16(1). 130–130. 2 indexed citations
3.
Xu, Haifeng, et al.. (2023). Intermittent fasting and immunomodulatory effects: A systematic review. Frontiers in Nutrition. 10. 1048230–1048230. 13 indexed citations
4.
Zhang, Ping, Chaoting Zhou, Xueying Ren, et al.. (2023). Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biology. 69. 103007–103007. 69 indexed citations
5.
Yan, Lijun, Xi Chen, Zhaolian Bian, et al.. (2022). A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma. Frontiers in Genetics. 13. 971364–971364. 8 indexed citations
6.
Xu, Haifeng, Bing Xu, Jiayu Hu, et al.. (2022). Development of a novel autophagy-related gene model for gastric cancer prognostic prediction. Frontiers in Oncology. 12. 1006278–1006278. 5 indexed citations
7.
Liu, Min, Yu Liu, Haifeng Xu, et al.. (2021). Chronic kidney disease: prevalence and association with handgrip strength in a cross-sectional study. BMC Nephrology. 22(1). 246–246. 7 indexed citations
9.
Yang, Huayu, Ziyi Yang, Xinting Sang, et al.. (2018). Diagnosis and treatment of primary hepatic lymphoma. Translational Cancer Research. 7(3). 720–728. 1 indexed citations
10.
Du, Shunda, Lijian Pei, Bo Zhu, et al.. (2017). Role of a selective cyclooxygenase-2 inhibitor on pain and enhanced recovery after open hepatectomy: a randomized controlled trial. Translational Cancer Research. 6(4). 806–814. 3 indexed citations
11.
Li, Huwei, et al.. (2017). Uncertainty analysis in risk-informed probabilistic safety assessment applications. Chinese Journal of Nuclear Science and Engineering. 37(5). 830–838.
12.
Du, Shunda, Lijian Pei, Bo Zhu, et al.. (2017). Role of a selective cyclooxygenase-2 inhibitor on pain and enhanced recovery after open hepatectomy: a randomized controlled trial. Translational Cancer Research. 6(4). 806–814. 6 indexed citations
13.
Du, Shunda, Gang Liu, Xinqi Cheng, et al.. (2016). Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma. Journal of Clinical Gastroenterology. 50(6). 501–505. 14 indexed citations
14.
Xu, Yiyao, Huayu Yang, Yilei Mao, et al.. (2016). Application of associating liver partition and portal vein ligation for staged hepatectomy(ALPPS) in cirrhotic patients with hepatocellular carcinoma. Zhonghua putong waike zazhi. 31(7). 534–537. 1 indexed citations
15.
Li, Wei, et al.. (2015). Transfer and concentration to marine aquatic biota for 14 C released from nuclear power plants. 35(2).
16.
Du, Shunda, Zi Wang, Xinting Sang, et al.. (2015). Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases. Medicine. 94(2). e388–e388. 26 indexed citations
17.
Zhao, Liangping, Weiting Xu, Li Wang, et al.. (2014). Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up. Coronary Artery Disease. 26(1). 5–10. 32 indexed citations
18.
Xiao, Haifeng, Shuying Zang, Ying Guan, et al.. (2014). Assessment of potential risks associated with heavy metal contamination in sediment in Aobaopao Lake, China, determined from sediment cores. Ecotoxicology. 23(4). 527–537. 32 indexed citations
19.
Xiao, Haifeng, Shuying Zang, Ying Guan, et al.. (2013). [Evolvement and pollution of heavy metals in core sediments from Yamenqi Lake in Lianhuan Lake, China].. Huan jing ke xue= Huanjing kexue. 34(8). 3088–94. 1 indexed citations
20.
Xu, Haifeng & Yousheng Mao. (2013). A brief comment on liver resection for hepatocellular carcinoma. Gastroenterology report. 1(3). 184–185. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026